Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](International Breast Cancer Study Group)"
Count: 42
Selected: 0
| NCT ID | Title |
|---|
| NCT02536742 | Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer | ||
| NCT02129556 | Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer | ||
| NCT01746225 | Schedules of Nab-Paclitaxel in Metastatic Breast Cancer | ||
| NCT00553410 | Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer | ||
| NCT00963417 | Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 | ||
| NCT00066807 | Premenopausal Endocrine Responsive Chemotherapy Trial | ||
| NCT00066703 | Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer | ||
| NCT02308085 | Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer | ||
| NCT00004205 | Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer | ||
| NCT00659373 | Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 | ||
| NCT00066690 | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer | ||
| NCT03820830 | Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer | ||
| NCT03644186 | To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) | ||
| NCT02954055 | MEtronomic TrEatment Option in Advanced bReast cAncer | ||
| NCT02393833 | IBCSG Trial 22-00 Serum Substudy | ||
| NCT02005887 | TRial on the Endocrine Activity of Neoadjuvant Degarelix | ||
| NCT01281137 | Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07 | ||
| NCT00975676 | Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 | ||
| NCT00899288 | Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98 | ||
| NCT00369850 | Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | ||
| NCT00343616 | Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | ||
| NCT00324714 | Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS | ||
| NCT00296010 | Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer | ||
| NCT00074152 | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer | ||
| NCT00072293 | Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases | ||
| NCT00022516 | Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer | ||
| NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | ||
| NCT00002529 | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer | ||
| NCT00002528 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer | ||
| NCT03513614 | Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) | ||
| NCT02889874 | EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer | ||
| NCT00062400 | Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer | ||
| NCT05063786 | Trial of Trastuzumab + ALpelisib +/- Fulvestrant vs Trastuzumab + Chemotherapy in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET) | ||
| NCT01101438 | A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer | ||
| NCT00003771 | Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer | ||
| NCT03045003 | Testing Two Different Intensities of an Intervention to Enhance REsilience and to Reduce SupportIve Care Needs in Cancer Patients | ||
| NCT00068601 | S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | ||
| NCT00045032 | Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer | ||
| NCT00066573 | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer | ||
| NCT00003140 | Letrozole After Tamoxifen in Treating Women With Breast Cancer | ||
| NCT00470236 | Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast | ||
| NCT03609047 | Adjuvant Palbociclib in Elderly Patients With Breast Cancer |
